References
  1. Perez Botero J, Lee K, Branchford BR, et al. Platelet Disorder Variant Curation Expert Panel. Glanzmann thrombasthenia: genetic basis and clinical correlates. Haematologica 2020;105:888-894.
  2. Ragsdell B, Thachil J. Lessons from recurrent deep vein thrombosis in Glanzmann thrombasthenia. Haemophilia 2013;19:e391-393.
  3. Girolami A, Sambado L, Bonamigo E, Vettore S, Lombardi AM. Occurrence of thrombosis in congenital thrombocytopenic disorders: a critical annotation of the literature. Blood Coagul Fibrinolysis 2013;24:18-22.
  4. Grinfeld J. Prognostic Models in the Myeloproliferative Neoplasms. Blood Rev 2020;42:100713.
  5. Campbell PJ, MacLean C, Beer PA, et al. Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort. Blood 2012;120:1409-1411.
  6. Connor DE, Ma DDF, Joseph JE. Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders. Thromb Res 2013;132:572-577.
  7. Griesshammer M, Beneke H, Nussbaumer B, Grünewald M, Bangerter M, Bergmann L. Increased platelet surface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia. Thromb Res 1996;96:191-196.
  8. Cesar JM, de Miguel D, García Avello A, Burgaleta C. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. Am J Clin Pathol 2005;123:772-777.
  9. Panova-Noeva M, Marchetti M, Russo L, et al. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera. Thromb Res 2013;132:88-93.
  10. Małecki R, Gacka M, Kuliszkiewicz-Janus M, et al. Altered plasma fibrin clot properties in essential thrombocythemia. Platelets 2015;7104:1-7.
  11. Sang Y, Roest M, de Laat B, de Groot PG, Huskens D. Interplay between platelets and coagulation [published online ahead of print 12 Jun 2020]. Blood Rev doi.org/10.1016/j.blre.2020.100733
  12. Lisman T, Adelmeijer J, Heijnen HF, de Groot PG. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation. Blood 2004;103:1720-7.
  13. Onselaer MB, Hardy AT, Wilson C, Sanchez X, Babar AK, Miller JLC, Watson CN, Watson SK, Bonna A, Philippou H, Herr AB, Mezzano D, Ariëns RAS, Watson SP. Fibrin and D-dimer bind to monomeric GPVI. Blood Adv 2017;1:1495-1504.
  14. Andrews RK, Arthur JF, Gardiner EE. Targeting GPVI as a novel antithrombotic strategy. J Blood Med 2014;5:59-68.
  15. Kenny M, Schoen I. A handshake between platelets and neutrophils might fuel deep vein thrombosis. Platelets 2020;31:624-626.
  16. Marín Oyarzún CP, Glembotsky AC, Goette NP et al. Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia. Front Immunol 2020;11:705.
  17. Mai V, Bertoletti L, Cucherat M, et al. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis. PLoS One 2019;14:e0214134.